Vaxcyte Long Term Debt from 2010 to 2024
PCVX Stock | USD 91.70 3.16 3.57% |
Long Term Debt | First Reported 2010-12-31 | Previous Quarter 405 K | Current Value 384.8 K | Quarterly Volatility 1.7 M |
Check Vaxcyte financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Vaxcyte's main balance sheet or income statement drivers, such as Interest Income of 66.1 M, Interest Expense of 0.0 or Selling General Administrative of 63.7 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 5.16. Vaxcyte financial statements analysis is a perfect complement when working with Vaxcyte Valuation or Volatility modules.
Vaxcyte | Long Term Debt |
Latest Vaxcyte's Long Term Debt Growth Pattern
Below is the plot of the Long Term Debt of Vaxcyte over the last few years. Long-term debt is a debt that Vaxcyte has held for over one year. Long-term debt appears on Vaxcyte balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Vaxcyte balance sheet is the sum of the balances of all categories of long-term debt. It is debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years. Vaxcyte's Long Term Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Vaxcyte's overall financial position and show how it may be relating to other accounts over time.
Long Term Debt | 10 Years Trend |
|
Long Term Debt |
Timeline |
Vaxcyte Long Term Debt Regression Statistics
Arithmetic Mean | 2,421,117 | |
Geometric Mean | 1,577,350 | |
Coefficient Of Variation | 69.46 | |
Mean Deviation | 1,591,593 | |
Median | 3,760,000 | |
Standard Deviation | 1,681,759 | |
Sample Variance | 2.8T | |
Range | 3.4M | |
R-Value | (0.86) | |
Mean Square Error | 810.2B | |
R-Squared | 0.73 | |
Significance | 0.000045 | |
Slope | (322,178) | |
Total Sum of Squares | 39.6T |
Vaxcyte Long Term Debt History
Other Fundumenentals of Vaxcyte
About Vaxcyte Financial Statements
Vaxcyte investors use historical fundamental indicators, such as Vaxcyte's Long Term Debt, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Vaxcyte. Please read more on our technical analysis and fundamental analysis pages.
Last Reported | Projected for Next Year | ||
Long Term Debt | 405 K | 384.8 K | |
Long Term Debt Total | 405 K | 384.8 K | |
Short and Long Term Debt Total | 29.2 M | 15.1 M | |
Long Term Debt To Capitalization | 0.10 | 0.09 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Vaxcyte Stock Analysis
When running Vaxcyte's price analysis, check to measure Vaxcyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxcyte is operating at the current time. Most of Vaxcyte's value examination focuses on studying past and present price action to predict the probability of Vaxcyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxcyte's price. Additionally, you may evaluate how the addition of Vaxcyte to your portfolios can decrease your overall portfolio volatility.